Cargando…

Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports

BACKGROUND: Malignancy risk may be increased in chronic inflammatory conditions that are mediated by tumor necrosis factor (TNF), such as juvenile idiopathic arthritis (JIA), but the role of TNF in human cancer biology is unclear. In response to a 2011 United States Food & Drug Administration re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hooper, Michele, Wenkert, Deborah, Bitman, Bojena, Dias, Virgil C, Bartley, Yessenia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851136/ https://www.ncbi.nlm.nih.gov/pubmed/24225257 http://dx.doi.org/10.1186/1546-0096-11-35

Ejemplares similares

The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis
por: Deodhar, Atul, et al.
Publicado: (2016)

Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
por: Hobbs, Kathryn, et al.
Publicado: (2015)

Summary of worldwide pediatric malignancies reported after exposure to etanercept
por: McCroskery, Peter, et al.
Publicado: (2010)

Guilt by association - what is the true risk of malignancy in children treated with etanercept for JIA?
por: Cron, Randy Q, et al.
Publicado: (2010)

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany
por: Moorkens, Evelien, et al.
Publicado: (2020)

Safety and Effectiveness of Etanercept Biosimilar SB4 for Rheumatic Diseases in South Korea: Real-World Post-marketing Surveillance Data
por: Yoo, Wan-Hee, et al.
Publicado: (2022)

The role of etanercept in juvenile dermatomyositis (JDMS) in children
por: Green, Katherine L, et al.
Publicado: (2014)

Etanercept biosimilars
por: Azevedo, Valderilio F., et al.
Publicado: (2014)

The lived experience of juvenile idiopathic arthritis in young people receiving etanercept
por: Livermore, P, et al.
Publicado: (2016)

Clinical utility of etanercept in the treatment of arthritides in children and adolescents
por: Dore, Robin K
Publicado: (2014)

Treatment of LADA With Etanercept
por: Montes, Vince N., et al.
Publicado: (2012)

Etanercept-associated myelitis
por: Finke, Carsten, et al.
Publicado: (2015)

Etanercept-associated Nephropathy
por: Ammar, Awais, et al.
Publicado: (2019)

Etanercept in axial spondyloarthritis
por: Luo, Gui, et al.
Publicado: (2022)

Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2016)

Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis
por: Koike, Takao, et al.
Publicado: (2011)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
por: Felis-Giemza, Anna, et al.
Publicado: (2019)

Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
por: Meijboom, Rosanne W., et al.
Publicado: (2021)

The Potential Role of Etanercept in the Management of Post-stroke Pain: A Literature Review
por: Joseph, Andrew M, et al.
Publicado: (2023)

Etanercept in the treatment of rheumatoid arthritis
por: Haraoui, Boulos, et al.
Publicado: (2007)

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

GP2015: An Etanercept Biosimilar
por: Deeks, Emma D.
Publicado: (2017)

Etanercept in erythema nodosum leprosum
por: Santos, Julia Rocha Silva, et al.
Publicado: (2017)

Etanercept improves pro-atherosclerotic biomarkers in children with juvenile idiopatic arthritis
por: Sara, De Sanctis, et al.
Publicado: (2011)

Influence of etanercept on leptin and ghrelin secretion in children with juvenile idiopathic arthritis
por: Maciejewska-Paszek, Izabela, et al.
Publicado: (2017)

Fecal microbiota in children with juvenile idiopathic arthritis treated with methotrexate or etanercept
por: Öman, Anders, et al.
Publicado: (2021)

Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence
por: Ignatowski, Tracey A., et al.
Publicado: (2014)

Summary of the evidence of heavy mesons
por: Hooper, John E
Publicado: (1953)

An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept
por: Livermore, P, et al.
Publicado: (2008)

Perispinal etanercept: Potential as an Alzheimer therapeutic
por: Griffin, W Sue T
Publicado: (2008)

The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007)

Infertility improved by etanercept in ankylosing spondylitis
por: Rezvani, Aylin, et al.
Publicado: (2008)

Treatment of ankylosing spondylitis: focus on etanercept
por: Frech, Tracy
Publicado: (2007)

Guidelines for the proper use of etanercept in Japan
por: Miyasaka, Nobuyuki, et al.
Publicado: (2006)

Pulmonary Sarcoidosis following Etanercept Treatment
por: Bhamra, Kuljeet, et al.
Publicado: (2012)

Minimal-change disease secondary to etanercept
por: Koya, Mariko, et al.
Publicado: (2012)

A case of figurate urticaria by etanercept
por: Sessa, Maurizio, et al.
Publicado: (2016)

Focus on biosimilar etanercept – bioequivalence and interchangeability
por: Cantini, Fabrizio, et al.
Publicado: (2018)

Correction to: GP2015: An Etanercept Biosimilar
por: Deeks, Emma D.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_afo7lhdergia8ssqah61o2urgb